Abstract:The gut microbiota is recognized as a contributor to host metabolic homeostasis, as obesity and diabetes are associated with unique gut microbiome signatures. Further, strategies aimed at beneficially shifting the gut microbiome, such as prebiotic treatment, show promise in ameliorating metabolic disease; however, the mechanisms are not yet understood. A potential contribution of the gut microbiota to host metabolism is via modification of host and diet-derived metabolites. For example, bile acids, crucial to lipid digestion and absorption, are modified by gut microbes in the small intestine. Bile acids have also been identified as signaling molecules in the intestine, liver, adipose, and nervous system, playing a role in metabolic homeostasis. Despite their importance, few studies have examined the impact of bile acid signaling on mediating the metabolic benefits of prebiotics. We hypothesized that bile acid homeostasis is altered with dietary factors that shift the gut microbiome, including high fat diet (HFD) feeding and supplementation with the prebiotic fiber oligofructose (OFS), and that taurocholic acid (TCA) and glycodeoxycholic acid (GDCA) that are increased with HFD feeding and OFS supplementation, respectively, would recapitulate the metabolic effects of these diets. Therefore, we conducted an untargeted metabolomics analysis on small intestinal contents of rats fed chow, HFD, or HFD supplemented with OFS, identifying bile acid metabolism as a primary contributor to the observed between-group differences. We then quantified bile acid levels in the small intestine, portal vein, and liver of rats fed chow, HFD, or HFD supplemented with OFS, and identified several bile acids of interest that are altered with HFD or OFS supplementation, including TCA and GDCA. Because these bile acids activate the bile acid receptors, FXR and TGR5, that known to impact metabolic homeostasis, we treated HFD-fed mice with 50 mg/kg GDCA or TCA daily for 12 weeks and measured body weight, adiposity, glucose tolerance, food intake, and indirect calorimetry. We found that GDCA treatment improved glucose tolerance, decreased body weight and adiposity, and increased energy expenditure compared to controls. Further, TCA worsened glucose tolerance independent of body weight. The results of this study implicate GDCA and TCA in the beneficial and detrimental effects of OFS and HFD-feeding, respectively; however, more research is necessary to determine the mechanism underpinning the metabolic effects of GDCA and TCA treatment. This work was supported by the NIH R01DK1804. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

The hepatokine orosomucoid 2 mediates beneficial metabolic effects of bile acids

Orosomucoid 2 Maintains Hepatic Lipid Homeostasis Through Suppression of De Novo Lipogenesis

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility

Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice

Bile acids altered by high fat feeding and oligofructose supplementation impact metabolic homeostasis

Integrative Systems Analysis Identifies Genetic and Dietary Modulators of Bile Acid Homeostasis

Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

The role of bile acids in regulating glucose and lipid metabolism.

Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model

Effects of Therapeutically Approved Individual Bile Acids on The Development of Metabolic Dysfunction-Associated Steatohepatitis a Low Bile Acid Mouse Model

The emerging role of bile acids in white adipose tissue

Bile Acid Signaling in Lipid Metabolism: Metabolomic and Lipidomic Analysis of Lipid and Bile Acid Markers Linked to Anti-Obesity and Anti-Diabetes in Mice.

Chemoproteomic Profiling of Bile Acid Interacting Proteins.

Targeting the alternative bile acid synthetic pathway for metabolic diseases

The molecular insights of bile acids homeostasis in host diseases

Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis

An integrated analysis of bile acid metabolism in humans with severe obesity

Targeting bile acid metabolism in obesity reduction: A systematic review and meta‐analysis

Bile Acid Derivatives Effectively Prevented High-Fat Diet-Induced Colonic Barrier Dysfunction